News

Read the full press release from Exact Sciences here. Joins two of the strongest brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growthForms best-in-class commercial, research, development and clinical organization, with enhanced scale and scope in cancer diagnosticsGlobal infrastructure accelerates the ability to provide new innovative cancer diagnostics to […]

Read the full press release here. Dr. Kim McDowell has been appointed to oversee the regulatory affairs of the Program for Advanced Cell Therapy (PACT). Her main duties will include crafting and managing investigational new drug (IND) and investigational device exemption (IDE) applications for PACT-sponsored clinical trials and regulatory compliance. “Dr. McDowell brings with her the […]

On June 11, 2019, BioFoward launched a Talent Initiative Campaign using marketing partner, Digital Ring, to develop brand awareness, visibility, and actions for BioForward member organizations. We are a little more than a month into the campaign, which will run through August, and the reach of the campaign thus far has been extensive.

Read the full press release from Business Wire here. BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced completion of construction on its 20,000 square foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility […]

Read the full article from BizTimes here. The Wisconsin Economic Development Corp. recently awarded a $400,000 grant to a Medical College of Wisconsin program focused on accelerating drug discoveries. MCW’s Therapeutic Accelerator Program, housed within the school’s Department of Pharmacology & Toxicology’s Drug Discovery Center, works with academic scientists to bring their drug discoveries from concept to […]

Read the full press release from BellBrook Labs here. Madison, WI – July 2019 – BellBrook Labs has been awarded a $300,000 SBIR grant by The National Institute of Allergy and Infectious Diseases (NIAID) to develop novel inhibitors for cyclic GAMP Synthase (cGAS), a promising therapeutic target for autoimmune diseases, including lupus. The enzyme cGAS […]